Year: 2005
Type: preprint
Study design: Observational Study
Abstract: Costs and Quality of Life in Multiple Sclerosis -A Cross-Sectional Study in the USA SUMMARYTreatment of multiple sclerosis (MS) has changed substantially during the past decade, as new biological disease-modifying treatments have been introduced in a field where only symptomatic pharmacological treatment had been available.The new treatments come at a high cost, between $ 8-12,000 per patient and year.Consequently, it must be expected that the part of total costs represented by drugs has increased, from essentially a very minor part in the nineties (2-5%) to a much larger proportion.However, no studies investigating this development from a societal perspective have so far been published.
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1526954907